2 research outputs found
Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target
MTH1
is a hydrolase responsible for sanitization of oxidized purine
nucleoside triphosphates to prevent their incorporation into replicating
DNA. Early tool compounds published in the literature inhibited the
enzymatic activity of MTH1 and subsequently induced cancer cell death;
however recent studies have questioned the reported link between these
two events. Therefore, it is important to validate MTH1 as a cancer
dependency with high quality chemical probes. Here, we present BAY-707,
a substrate-competitive, highly potent and selective inhibitor of
MTH1, chemically distinct compared to those previously published.
Despite superior cellular target engagement and pharmacokinetic properties,
inhibition of MTH1 with BAY-707 resulted in a clear lack of <i>in vitro</i> or <i>in vivo</i> anticancer efficacy
either in mono- or in combination therapies. Therefore, we conclude
that MTH1 is dispensable for cancer cell survival
Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target
MTH1
is a hydrolase responsible for sanitization of oxidized purine
nucleoside triphosphates to prevent their incorporation into replicating
DNA. Early tool compounds published in the literature inhibited the
enzymatic activity of MTH1 and subsequently induced cancer cell death;
however recent studies have questioned the reported link between these
two events. Therefore, it is important to validate MTH1 as a cancer
dependency with high quality chemical probes. Here, we present BAY-707,
a substrate-competitive, highly potent and selective inhibitor of
MTH1, chemically distinct compared to those previously published.
Despite superior cellular target engagement and pharmacokinetic properties,
inhibition of MTH1 with BAY-707 resulted in a clear lack of <i>in vitro</i> or <i>in vivo</i> anticancer efficacy
either in mono- or in combination therapies. Therefore, we conclude
that MTH1 is dispensable for cancer cell survival